Investments

NCCN and Pfizer Fund Projects to Improve Prostate Cancer Care
Management & Regulatory NCCN and Pfizer Fund Projects to Improve Prostate Cancer Care

Reducing the logistical and financial hurdles associated with prostate cancer treatment is a primary goal of the latest round of quality improvement funding. This initiative, spearheaded by the National Comprehensive Cancer Network Oncology Research Program in partnership with Pfizer Global Medical

CordenPharma Expands Sterile Injectable Capacity in Italy
Management & Regulatory CordenPharma Expands Sterile Injectable Capacity in Italy

CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its capabilities in assembling auto-injectors and other complex drug delivery formats for chronic disease management. As the global pharmaceutical market shifts towards self-administered therapies, the demand

Namibia Unveils First Public MRI to Boost Healthcare Equity
Management & Regulatory Namibia Unveils First Public MRI to Boost Healthcare Equity

The high cost of referring more than 4,000 state patients to private facilities for imaging services has historically drained approximately 16 million Namibian dollars from the public budget every year. This financial burden often meant that essential funds were diverted from other critical areas,

Mexico Mandates Nationwide Digital Health Integration by 2026
Management & Regulatory Mexico Mandates Nationwide Digital Health Integration by 2026

The success of the 2026 mandate hinges on the ability of rural clinics to access the same high-quality digital history as specialized private hospitals in Mexico City. By fundamentally altering the General Health Law, the federal government has declared digital health a matter of absolute public

Minimally Invasive Medical Robot Market to Hit $65 Billion by 2030
Tech & Innovation Minimally Invasive Medical Robot Market to Hit $65 Billion by 2030

The objective of deploying high-precision robotics in the operating room is to provide a level of accuracy that exceeds the natural physical limitations of the human hand. This pursuit of surgical excellence has catalyzed a global healthcare transformation, moving away from traditional invasive

Superluminal Medicines Raises $60M for Rare Obesity Drug
Research & Development Superluminal Medicines Raises $60M for Rare Obesity Drug

By targeting the MC4R receptor with a small-molecule approach, Superluminal Medicines seeks to provide relief for patients suffering from hyperphagia and rare metabolic defects. This ambitious goal is now backed by a significant $60 million Series A funding round led by RA Capital Management, with

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later